rolipram has been researched along with Peripheral Nerve Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chłoń-Rzepa, G | 1 |
| Ślusarczyk, M | 1 |
| Jankowska, A | 1 |
| Gawalska, A | 1 |
| Bucki, A | 1 |
| Kołaczkowski, M | 1 |
| Świerczek, A | 1 |
| Pociecha, K | 1 |
| Wyska, E | 1 |
| Zygmunt, M | 1 |
| Kazek, G | 1 |
| Sałat, K | 1 |
| Pawłowski, M | 1 |
| Gordon, T | 1 |
| Chan, KM | 1 |
| Sulaiman, OA | 1 |
| Udina, E | 1 |
| Amirjani, N | 1 |
| Brushart, TM | 1 |
1 review available for rolipram and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Accelerating axon growth to overcome limitations in functional recovery after peripheral nerve injury.
Topics: Animals; Cyclic AMP; Disease Models, Animal; Electric Stimulation Therapy; Growth Cones; Humans; Ner | 2009 |
1 other study available for rolipram and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4/7 inhibitors: A new approach for the treatment of pain.
Topics: Amides; Analgesics; Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phospho | 2018 |